Development of the Japanese version of the COPD Assessment Test

Respiratory Investigation

Volumn 50, Issue 2, 2012, Pages 34-39

  Tsuda, Tohru ^a   Suematsu, Rika ^a   Kamohara, Kumie ^b   Kurose, Mariko ^b   Arakawa, Ichiro ^c,e   Tomioka, Ryusuke ^d   Kawayama, Tomotaka ^d   Hoshino, Tomoaki ^d   Aizawa, Hisamichi ^d  

^a Kirigaoka Tsuda Hospital   (Japan)

^b Fukuoka Gender Studies Institute   (Japan)

^c Development and Medical Affairs Division   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TEIKYO HEISEI UNIVERSITY   (Japan)

Author keywords

Chronic obstructive pulmonary disease (COPD); COPD Assessment Test (CAT); Questionnaire; Reliability; Validity

Indexed keywords

ASIAN CONTINENTAL ANCESTRY GROUP; HEALTH STATUS; HUMAN; JAPAN; LANGUAGE; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SELF EVALUATION; SMOKING; VALIDATION STUDY;

ASIAN CONTINENTAL ANCESTRY GROUP; DIAGNOSTIC SELF EVALUATION; HEALTH STATUS; HUMANS; JAPAN; LANGUAGE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SMOKING;

EID: 84868287139     PISSN: 22125345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resinv.2012.05.003     Document Type: Article

References (12)

1. Vital Statistics of Japan 2010: Table 5-11 Annual ranking of causes of death (Online), available from [accessed 12.02.01] [published in Japanese]. http://www.e-stat.go.jp/.
2. Committee for the Third Edition of the COPD Guidelines of the Japanese Respiratory Society. Chapter 1. Definition, epidemiology, risk factors, pathology, and etiology. Section F. Pathophysiology. In: Guidelines for the Diagnosis and Treatment of COPD (Chronic Obstructive Pulmonary Disease). Third Edition. Tokyo: Medical Review; 2009. p. 23-9 [published in Japanese].
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Chapter 1. Definition and overview. Pathology, pathogenesis and pathophysiology. In: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [revised 2011]. pp. 1-7 [online]. Available from: [accessed 12.02.01]. http://www.goldcopd.org/.
4. Ichinose M., Aizawa H., Ishizaka A., et al. Chronic obstructive pulmonary disease (COPD) burden in Japan-Confronting COPD Japan survey. J Jpn Respir Soc 2007, 45:927-935. [published in Japanese with an English abstract].
5. Jones P.W., Quirk F.H., Baveystock C.M., et al. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
6. Guyatt G.H., Berman L.B., Townsend M., et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987, 42:773-778.
7. Jones P.W., Harding G., Berry P., et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009, 34:648-654.
8. Meguro M., Barley E.A., Spencer S., et al. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest 2007, 132:456-463.
9. Wild D., Grove A., Martin M., et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value Health 2005, 8:94-104.
10. Cronbach L. Coefficient alpha and the internal structure of tests. Phychometrika 1951, 16:297-334.
11. Chassany O., Sagnier P., Marquis P., et al. Patient-reported outcomes: The example of health-related quality of life-A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Info J 2002, 36:209-238.
12. Curtis J.R., Martin D.P., Martin T.R. Patient-assessed health outcomes in chronic lung disease. Am J Respir Crit Med 1997, 156:1032-1039.